Treatment results of children with chronic immune thrombocytopenic purpura (ITP) treated with rituximab

Journal of Tropical Pediatrics

Volumn 57, Issue 1, 2011, Pages 71-72

  Citak, Elvan Caglar ^a   Citak, Funda Erkasar ^b  

^a Gaziantep Children Hospital   (Turkey)

^b Ankara Foundation of Children with Leukemia   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RITUXIMAB;

ADOLESCENT; ARTHRALGIA; CHILD; CHILL; CLINICAL ARTICLE; DISEASE DURATION; DRUG ERUPTION; DRUG FEVER; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; MALAISE; MALE; PRESCHOOL CHILD; RELAPSE; SCHOOL CHILD; SERUM SICKNESS; SPLENECTOMY; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE; URTICARIA; VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 79251642500     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq033     Document Type: Letter

References (6)

1. Tamminga RY, Bruin MC. Rituximab treatment for symptomatic chronic ITP. Pediatr Blood Cancer 2006;47:714-716.
2. Rao A, Kelly M, Musselman M, et al. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. Pediatr Blood Cancer 2008;50:822-5.
3. Wang J, Wiley JM, Luddy R, et al. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr 2005;146:217-21.
4. Taube T, Schmid H, Reinhard H, et al. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica 2005;90:281-3.
5. Bennet CM, Rogers ZR, Kinnamon DD, et al. Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic. Blood 2006;107:2639-42.
6. Parodi E, Rivetti E, Amendola G, et al. Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response. Br J Haematol 2009;144:552-8.